SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-17-209447
Filing Date
2017-06-21
Accepted
2017-06-21 16:35:03
Documents
7
Period of Report
2017-06-21
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d416123d8k.htm 8-K 17491
2 EX-1.1 d416123dex11.htm EX-1.1 193746
3 EX-5.1 d416123dex51.htm EX-5.1 8431
4 EX-99.1 d416123dex991.htm EX-99.1 8537
5 GRAPHIC g416123ex51pg1a.jpg GRAPHIC 539
6 GRAPHIC g416123ex51pg1b.jpg GRAPHIC 541
7 GRAPHIC g416123g0621220601673.jpg GRAPHIC 4316
  Complete submission text file 0001193125-17-209447.txt   237329
Mailing Address 501 CANAL BLVD POINT RICHMOND TECH CNTR. RICHMOND CA 94804
Business Address 501 CANAL BLVD POINT RICHMOND TECH CNTR. RICHMOND CA 94804 5109706000
SANGAMO THERAPEUTICS, INC (Filer) CIK: 0001001233 (see all company filings)

IRS No.: 680359556 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-30171 | Film No.: 17923199
SIC: 2836 Biological Products, (No Diagnostic Substances)